Avantor Bridgewater Innovation Center; Bridgewater, NJ

Size: 27,000 sf

Project team: Avantor utilized a project team of experts that to execute a vision to create a facility that encouraged customer collaboration, a key element of the lab’s innovation model. Avantor internal team (laboratory layout, workflow design, equipment selection and placement), Advance Realty (building management). 

Description: Avantor®, a global supplier of ultra-high-purity materials for customers across the life sciences and advanced technologies sectors, recently opened a new research center in Bridgewater, New Jersey to help biopharmaceutical and pharmaceutical customers with a full range of upstream and downstream processes, from gene to protein expression through final formulation and drug delivery.

Housed within the New Jersey Center of Excellence, a 110-acre life sciences campus centrally located in the northeast U.S. bioscience technology corridor, Avantor’s research facility is close to notable learning institutions including Princeton University, Rutgers University, and the New Jersey Institute of Technology.

Avantor’s Bridgewater Innovation Center was specifically designed as an innovation hub that encourages customer interaction and collaboration with the company’s collective of entrepreneurial scientists and associates who have diverse backgrounds in life science and materials science disciplines.

Similar to a contract research organization, the lab has broad capabilities to work with customers and serve as an agile extension of their own R&D departments. The Bridgewater Innovation Center features state-of-the-art life sciences and advanced materials research tools, including cleanroom facilities, multiple mass spectrometers, specially constructed bioreactors, particle size analyzers and more.

The facility houses multiple research platforms to address issues such as facilitating recombinant protein engineering, protein expression, purification and trace materials characterization. There are also research platforms to investigate new excipient formulations to enhance API stability.
In addition, research and development on advanced materials for customers in the aerospace and defense and semiconductor industries, with chemistries that require purity at the parts-per-trillion level, are also conducted.

Completion date: Lab operation began in Spring 2017

Contact person: Allison Hosak, Senior Vice President, Global Communications, 610-573-2661,